Emcure Pharmaceuticals Limited will merge its wholly owned subsidiaries Zuventus Healthcare Limited and Emcutix Biopharmaceuticals Limited into itself under a board-approved Composite Scheme of Amalgamation aimed at simplifying structure and improving efficiency, with no cash payment, no new share issuance and no change in shareholding.